“abbott-laboratories” Archives

Entry Author Date Location
Genzyme Initiates Job Cuts, Dana-Farber/Gatekeeper Suit Advances, GTC Bought by LFB, & More Boston-Area Life Sciences News 11/12/10 Boston
Kamen Joins Third Rock Ventures 11/10/10 Boston
Amgen, Abbott Win BayBio Awards 11/05/10 San Francisco
ChemoCentryx, Pursuing the Dream For Autoimmune Disease, Seeks to Put a Pill in a Bottle 11/04/10 San Francisco
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology 11/03/10 Boston
Arena Obesity Drug Fails to Win FDA Approval, May Need More Clinical Testing 10/25/10 San Diego
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis 10/20/10 San Diego
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010 09/20/10 San Francisco
Former Solvay Pharma Chief Takes Lead Role at Startup Selecta Biosciences 08/16/10 Boston
Concert Pharma Riding Potential $1B Glaxo Deal, Looks Ahead to Human Data on HIV Drug 07/14/10 Boston
Future Biotech Winners Will Help Nurses Clean up Less (Stuff), Says Roger Longman 06/28/10 National
San Diego’s Neurocrine Biosciences Scores Second Big Deal in Two Days 06/18/10 San Diego
Neurocrine Inks Deal with Abbott 06/16/10 San Diego
T2 Biosystems Nails Down $15M For Portable Diagnostic with the Punch of a Desktop 05/25/10 Boston
Seventh Sense, Rox Anderson and Bob Langer Startup, Seeks to Collect Blood With No Pain 05/20/10 Boston
Alder, Bristol Arthritis Drug Shows “Outstanding” Results in Trial, Lead Researcher Says 05/17/10 Seattle
Lycera Keeps Its Investors Happy, Snags $11M to Pursue New Autoimmune Drugs 04/28/10 Detroit Ann Arbor
Gene Network Sciences Using Supercomputing to Match Patients with a Drug That Works 04/27/10 Boston
Amplyx Pharmaceuticals, Led By Women, Builds Platform for Improving Drugs for HIV, Cancer 04/20/10 San Diego
Mersana Strikes Deal With Teva Worth up to $334M for Long-Lasting Cancer Drug 04/13/10 Boston
The Pharmaceutical R&D Model is Broken. Here’s How to Fix It 03/05/10 Seattle
BG Medicine Taking Second Shot at Public Market, Proposes $86.3M IPO 01/29/10 Boston
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Ensemble Discovery Nabs Second Partner, Pfizer, to Develop New Class of Therapies 01/06/10 Boston
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News 11/12/09 Seattle
Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News 11/11/09 Boston
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money 11/11/09 Seattle
Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion 11/10/09 Seattle
Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill 11/09/09 Boston
Enlight Biosciences Forms Partnership with Abbott Labs 11/04/09 Boston
Page 3 of 4 « previous page · next page »